Provexis Plc (PXS.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 09-2025 | 03-2025 | 09-2024 | 03-2024 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 523 | 708 | 478 | 189 | 319 |
| Inventories | 44 | 202 | 153 | 137 | 146 |
| Other current assets | 275 | 102 | 191 | 172 | 305 |
| TOTAL | $842 | $1,012 | $822 | $498 | $770 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $842 | $1,012 | $822 | $498 | $770 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 219 | 28 | 471 | 21 | 319 |
| TOTAL | $231 | $248 | $471 | $307 | $319 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 534 | 534 | 534 | 534 | 532 |
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $231 | $248 | $471 | $307 | $319 |
| Shareholders' Equity | |||||
| Common Shares | 2,346 | 2,346 | 2,263 | 2,218 | 2,218 |
| Retained earnings | -27,236 | -27,080 | -26,906 | -26,796 | -26,537 |
| Other shareholders' equity | 6,602 | 6,599 | 6,599 | 6,599 | 6,599 |
| TOTAL | $1,145 | $1,298 | $885 | $724 | $983 |
| Total Liabilities And Equity | $1,376 | $1,546 | $1,356 | $1,032 | $1,302 |